Welcome to SuperLan Chemical Co.,Ltd.
Home > Products > Cell Cycle > Aurora Kinase > Reversine

Reversine

(CAS No:656820-32-5)
Reversine is a potent human A3 adenosine receptor antagonist with Ki of 0.66 μM, and a pan-aurora A/B/C kinase inhibitor with IC50 of 12 nM/13 nM/20 nM, respectively. Also used for stem cell dedifferentiation.
CAS No:656820-32-5
Molecular Weight(MW):393.23
Purity:99.00%
Specification:500MG;1G;5G;10G;50G;100G
Price and large packaging, please e-mail consultation:info@SuperLan-chem.com
QC Documents
 COA  MSDS  HPLC  NMR
ChemicalInfomation
CAS No: 656820-32-5
Molecular formula(MF) C21H27N7O
Molecular Weight(MW): 393.23
Alias
Solubility
In vitro DMSO 5 mg/mL warmed (12.71 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo
Biological Activity
Description Reversine is a potent human A3 adenosine receptor antagonist with Ki of 0.66 μM, and a pan-aurora A/B/C kinase inhibitor with IC50 of 12 nM/13 nM/20 nM, respectively. Also used for stem cell dedifferentiation.
Targets
Aurora A [3] Aurora B [3] Aurora C [3] human A3 adenosine receptor [2]
12 nM 13 nM 20 nM 0.66 μM(Ki)
In vitro

Reversine induces myogenic lineage-committed cells to become multipotent mesenchymal progenitor cells, which proliferates and redifferentiates into bone and fat cells. [1] Reversine, as an A3 adenosine receptor antagonist, competitively inhibits forskolin-stimulated cAMP production in stably transfected Chinese hamster ovary (CHO) cells. [2] Reversine inhibits the phosphorylation of a well-known Aurora target, histone H3 in HCT116 cells. Moreover, Reversine potently blocks proliferation of multiple tumor cell types, and induces cell death. In primary human tumor samples, Reversine also inhibits colony formation of leukemic cells. [3] When treated in combination, reversine and aspirin synergistically inhibit growth of cervical cancer cells and induce cell apoptosis. [4]

In vivo In mice inoculated with U14 tumors, Reversine (10 mg/kg i.p.) and aspirin cause more reduced tumor weight and tumor volume when compared with the control agents. [4]